News from the FDA/CDC

FDA authorizes Pfizer antiviral pill for COVID-19

Publish date: December 22, 2021

 

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

12 state boards have disciplined docs for COVID misinformation
MDedge Psychiatry
COVID-19 asymptomatic infection rate remains high
MDedge Psychiatry
Even COVID-19 can’t stop a true optimist
MDedge Psychiatry
A pandemic silver lining? Dramatic drop in teen drug use
MDedge Psychiatry
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
MDedge Psychiatry
Advisory on youth mental health crisis gets mixed reviews
MDedge Psychiatry
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
MDedge Psychiatry
COVID cases spike as questions remain about Omicron’s threat
MDedge Psychiatry
COVID-19 and coping with superimposed traumas
MDedge Psychiatry
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
MDedge Psychiatry